Showing results (21-30 of 66) with videos related to

Sort By:
Pageof 7
World Journal of Surgical Oncology|August 5, 2022
Risk predictive model based on three immune-related gene pairs to assess prognosis and therapeutic sensitivity for hepatocellular carcinomaBaifeng Qian, Haozhong Lin, Tian Lan, et al.
Frontiers in Molecular Biosciences|December 28, 2020
Four Immune-Related Long Non-coding RNAs for Prognosis Prediction in Patients With Hepatocellular CarcinomaMuqi Li, Minni Liang, Tian Lan, et al.
European Radiology|January 15, 2021
Regional liver function analysis with gadoxetic acid-enhanced MRI and virtual hepatectomy: prediction of postoperative short-term outcomes for HCCMengqi Huang, Shunli Shen, Huasong Cai, et al.
Journal of Gastroenterology and Hepatology|April 5, 2020
Hepatic resection versus transarterial chemoembolization in infiltrative hepatocellular carcinoma: A multicenter studyYuanqi Wang, Jingxian Shen, Shiting Feng, et al.
Aging|December 24, 2018
Overexpression of FoxM1 predicts poor prognosis of intrahepatic cholangiocarcinomaLingyun Liu, Jian Wu, Yu Guo, et al.
Oncology Reports|February 6, 2018
NEK2 promotes hepatocellular carcinoma migration and invasion through modulation of the epithelial-mesenchymal transitionYi Zhang, Wei Wang, Yifei Wang, et al.
Journal of Investigative Surgery : the Official Journal of the Academy of Surgical Research|February 19, 2020
High SPINK1 Expression Predicts Poor Prognosis and Promotes Cell Proliferation and Metastasis of Hepatocellular CarcinomaKaijun Huang, Wenxuan Xie, Shutong Wang, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 17, 2017
Nomogram to Predict Survival of Patients With Recurrence of Hepatocellular Carcinoma After SurgeryWei He, Baogang Peng, Yunqiang Tang, et al.
The Oncologist|August 4, 2016
Is Salvage Liver Resection Necessary for Initially Unresectable Hepatocellular Carcinoma Patients Downstaged by Transarterial Chemoembolization? Ten Years of ExperienceYingqiang Zhang, Guihua Huang, Yu Wang, et al.
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology|May 5, 2021
Pristimerin synergistically sensitizes conditionally reprogrammed patient derived-primary hepatocellular carcinoma cells to sorafenib through endoplasmic reticulum stress and ROS generation by modulating Akt/FoxO1/p27<sup>kip1</sup> signaling pathwayYubo Tang, Jie Chen, Jiaqi Li, et al.
Pageof 7